EZH2 and BCL6 cooperate to assemble CBX8-BCOR complex to repress bivalent promoters, mediate germinal center formation and lymphomagenesis Journal Article


Authors: Béguelin, W.; Teater, M.; Gearhart, M. D.; Calvo Fernández, M. T.; Goldstein, R. L.; Cárdenas, M. G.; Hatzi, K.; Rosen, M.; Shen, H.; Corcoran, C. M.; Hamline, M. Y.; Gascoyne, R. D.; Levine, R. L.; Abdel-Wahab, O.; Licht, J. D.; Shaknovich, R.; Elemento, O.; Bardwell, V. J.; Melnick, A. M.
Article Title: EZH2 and BCL6 cooperate to assemble CBX8-BCOR complex to repress bivalent promoters, mediate germinal center formation and lymphomagenesis
Abstract: The EZH2 histone methyltransferase mediates the humoral immune response and drives lymphomagenesis through formation of bivalent chromatin domains at critical germinal center (GC) B cell promoters. Herein we show that the actions of EZH2 in driving GC formation and lymphoma precursor lesions require site-specific binding by the BCL6 transcriptional repressor and the presence of a non-canonical PRC1-BCOR-CBX8 complex. The chromodomain protein CBX8 is induced in GC B cells, binds to H3K27me3 at bivalent promoters, and is required for stable association of the complex and the resulting histone modifications. Moreover, oncogenic BCL6 and EZH2 cooperate to accelerate diffuse large B cell lymphoma (DLBCL) development and combinatorial targeting of these repressors results in enhanced anti-lymphoma activity in DLBCLs. © 2016 Elsevier Inc.
Journal Title: Cancer Cell
Volume: 30
Issue: 2
ISSN: 1535-6108
Publisher: Cell Press  
Date Published: 2016-08-08
Start Page: 197
End Page: 213
Language: English
DOI: 10.1016/j.ccell.2016.07.006
PROVIDER: scopus
PMCID: PMC5000552
PUBMED: 27505670
DOI/URL:
Notes: Article -- Export Date: 2 November 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ross Levine
    775 Levine